Kewaunee Scientific CorporationKEQUNASDAQ
Loading
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue Growth | +43.59% | +36.06% | +46.93% | +46.75% | +3.32% |
| Gross Profit Growth | +52.79% | +64.19% | +67.60% | +41.34% | +0.90% |
| EBITDA Growth | -13.25% | +325.61% | +75.60% | +17.67% | +5.13% |
| Operating Income Growth | -40.88% | +52.93% | +86.80% | -7.37% | +14.76% |
| Net Income Growth | -46.29% | -56.01% | +41.04% | -18.72% | -48.89% |
| EPS Growth | -45.98% | -55.96% | +40.26% | -19.05% | -48.94% |
| EPS Diluted Growth | -47.06% | -56.06% | +40.54% | -18.81% | -48.89% |
| Weighted Average Shares Growth | -0.73% | -0.14% | +0.07% | -0.45% | -0.21% |
| Weighted Average Shares Diluted Growth | +1.01% | +0.30% | -0.13% | +0.10% | -0.40% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -123.85% | +721.57% | +0.00% | -150.56% | +0.00% |
| Free Cash Flow Growth | -132.74% | +5256.02% | +0.00% | -175.26% | +0.00% |
| Receivables Growth | +39.68% | +0.00% | +30.66% | +40.90% | -5.73% |
| Inventory Growth | +44.47% | +58.85% | +81.09% | +90.25% | +4.27% |
| Asset Growth | +49.75% | +44.44% | +46.56% | +40.60% | -6.97% |
| Book Value per Share Growth | +38.93% | +17.87% | +19.65% | +18.27% | +16.48% |
| Debt Growth | +40.75% | +28.16% | +65.14% | +468.35% | +6.37% |
| R&D Expense Growth | +0.00% | -0.11% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +96.14% | +71.09% | -100.00% | -100.00% | -100.00% |